Valvular heart disease
Prognostic Value of Aortic Valve Area Index in Asymptomatic Patients With Severe Aortic Stenosis

https://doi.org/10.1016/j.amjcard.2012.02.056Get rights and content

Recently, an aortic valve area (AVA) index (AVAI) <0.6 cm2/m2 was proposed as an indicator of severe aortic stenosis. The purpose of the present study was to clarify the prognostic value of the AVAI. We identified 103 consecutive asymptomatic patients (mean age 72 ± 11 years) with severe aortic stenosis, defined by an AVA of <1.0 cm2, who had not undergone aortic valve replacement on initial evaluation. During follow-up (median 36 ± 27 months), 31 aortic valve replacements and 20 cardiac deaths occurred. Multivariate analysis revealed that an AVAI <0.6 cm2/m2 (hazard ratio 2.6, 95% confidence interval 1.1 to 6.3; p = 0.03) and peak aortic jet velocity (Vp) >4.0 m/s (hazard ratio 2.6, 95% confidence interval 1.2 to 5.8; p = 0.02) were associated with cardiac events but that an AVA <0.75 cm2 was not. The event-free survival of patients with an AVAI of ≥0.6 cm2/m2 was better than that for those with an AVAI <0.6 cm2/m2 (86% vs 41% at 3 years, p <0.01). Furthermore, patients with an AVAI of ≥0.6 cm2/m2 and Vp of ≤4.0 m/s showed an excellent prognosis, but those without these findings had poorer outcomes. In conclusion, AVAI is a powerful predictor of adverse events in asymptomatic patients with severe aortic stenosis. Furthermore, the combination of AVAI and Vp provides additional prognostic information. Watchful observations are required for timely aortic valve replacement in patients with an AVAI of <0.6 cm2/m2 or a Vp >4.0 m/s.

Section snippets

Methods

From 2001 to 2007, asymptomatic patients who underwent transthoracic echocardiography and had severe AS, defined as an AVA of <1.0 cm2, were retrospectively identified for the present study if they had not undergone aortic valve replacement on initial evaluation. The exclusion criteria were a history of coronary artery disease (diagnosed by clinical, electrocardiographic, echocardiographic, and coronary angiographic evaluation), more than mild mitral valve regurgitation or stenosis, more than

Results

The mean duration of follow-up was 36 ± 27 months. Of the study group, 37 patients had an AVAI of ≥0.6 cm2/m2, and 66 patients had an AVAI of <0.6 cm2/m2. Compared to patients with AVAI of ≥0.6 cm2/m2, those with an AVAI <0.6 cm2/m2 did not significantly differ in age, gender, LV ejection fraction, co-morbidities, C-reactive protein, or serum creatinine but exhibited a smaller AVA, higher Vp, greater peak and mean aortic pressure gradient, and larger body surface area. The baseline patient

Discussion

This is the first study to assess the outcomes on the basis of an AVAI. The present study demonstrated that an AVAI of ≥0.6 cm2/m2 was frequently observed in patients with an AVA <1.0 cm2. Patients with an AVAI of ≥0.6 cm2/m2 had better outcomes than those with an AVAI <0.6 cm2/m2. Multivariate analysis showed that an AVAI <0.6 cm2/m2 and Vp >4.0 m/s were significant predictors of adverse cardiac events, but an AVA <0.75 cm2 was not. Patients with an AVAI <0.6 cm2/m2 or peak velocity >4.0 m/s

References (21)

There are more references available in the full text version of this article.

Cited by (43)

  • Simple echocardiographic scoring in screening aortic stenosis with focused cardiac ultrasonography in the emergency department

    2021, Journal of Cardiology
    Citation Excerpt :

    The main results of the present study were: 1) the observation of a strong correlation between the visual AS score for POC-echo performed by emergency physicians and the AVAI for STD-echo performed by expert sonographers; 2) a visual AS score ≥3 for POC-echo performed by emergency physicians had an excellent diagnostic accuracy for moderate or severe AS; and 3) the prevalence of new-onset AS-related events during hospitalization was higher in patients with visual AS score ≥3, as assessed by POC-echo in the emergency department, than in those with visual AS score <3. AS is a progressive and life-threatening disease that carries the risk of severe congestive heart failure, cardiogenic shock, or sudden cardiac death in a symptomatic or even in an asymptomatic stage [10,19–21]. Degenerative AS is one of the most common valvular diseases, especially in elderly populations.

View all citing articles on Scopus
View full text